Will insurance in the UAE cover new obesity pills like Foundayo or Wegovy?

Not necessarily—at least not yet. Even though Foundayo has been approved by the Emirates Drug Establishment, insurance coverage is still uncertain and varies by provider. Basic health plans typically do not cover weight-loss medications, as obesity has often been treated as a lifestyle issue rather than a core medical benefit. Some premium plans may offer coverage, but usually only if the drug is prescribed for related conditions like Type 2 Diabetes, hypertension, or cardiovascular risks—and even then, it depends on the insurer’s approved drug list. Insurers usually take time to evaluate new treatments based on clinical evidence, cost impact, and long-term outcomes, meaning any coverage rollout is likely to be gradual and inconsistent across the market. Do you think insurers should treat obesity as a medical condition and cover such treatments, or keep them outside standard plans?

Add your Comment:

+